Pancreatic cancer is still deadly – 16.11.2018


On the occasion of the World Panic Cancer Day on 15 November, European work emphasizes that the mortality rate for this type of cancer increased by 5% between 1990 and 2016. of the largest increase among the five deadliest tumors. This is a lack of funding for research.

Pancreatic cancer affects 11,600 people every year in France and this data is increasing. Detected often late in the absence of varying clinical signs, it is unfortunately aggressive cancer, which is estimated to be 2E the cause of cancer death by 2030.

European work under leadershipUnited European Gastroenterology (a group of European companies affected by digestive factors) confirms this. Pancreatic cancer has the lowest survival rate for all types of cancer in Europe. Responsible for more than 95,000 deaths in the EU each year, the average survival time is only 4.6 months in the diagnosis. Thus, the mortality rate increased by 5% between 1990 and 2016!

The problem, according to experts, " Research on cancer of the pancreas represents only 2% of the resources allocated to cancer research in Europe. In order to establish earlier diagnoses and improve treatment, we now have to undertake further basic research. " Scientists are also urging the European Union to take the path of funding.

Route of microbiology

Scientists explain that research can quickly produce good results. After forty years of limited progress in the field of cancer research, the pancreas says that new treatment options can ultimately be on the horizon, focusing on pancreatic microflora. In fact, the microbial population of the pancreatic cancer is about 1,000 times larger than non-pancreatic cancer, and research has shown that the removal of bacteria from the intestine and pancreas slows cancer growth and reprograms immune cells to respond to cancer cells.

Source link